Related Experiment Videos
[Antianginal therapy '95]
1I. interní klinika FN U sv. Anny LF MU, Brno.
Insights
This review outlines current antianginal treatment strategies, focusing on therapeutic algorithms for cardiac ischemia and angina pectoris. It details medication options and their timing relative to revascularization procedures.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Review of contemporary antianginal treatment options.
- Discussion of pathophysiological and morphological aspects of cardiac ischemia and angina pectoris.
Purpose:
- To provide evidence-based algorithms for therapeutic decisions in managing angina pectoris.
- To detail the role of both pharmacotherapy and revascularization in treatment strategies.
Summary:
- The review covers nitrates, beta-blockers, calcium channel inhibitors, and antithrombotics, including their mechanisms, indications, contraindications, side effects, and dosages.
- It emphasizes the integration of medication with invasive procedures like revascularization, offering guidance for timing and application.
- Angiotensin-converting enzyme inhibitors are also mentioned as part of the therapeutic landscape.
Impact:
- Aims to guide clinicians in optimizing treatment strategies for patients with angina pectoris.
- Highlights the evolving nature of antianginal treatment based on advancing medical knowledge.
Abstract:
The submitted review deals with contemporary possibilities of antianginal treatment. After a brief account of pathophysiological and morphological data in different types of cardiac ischaemia and angina pectoris the author submits algorithms which should be the basis for therapeutic decisions. It is a question of proper timing of invasive examinations leading to revascularization operations in relation to medicamentous treatment. The latter is supplementary treatment before or after revascularization, or is the main approach in case of minimal complaints, in case of contraindicated invasive treatment or in case of an inoperable finding. The author discusses the action, indications, contraindications, undesirable effects, and average dosage of nitrates, beta-blockers, calcium channel inhibitors and antithrombotics. The author mentions also the use of angiotensin converting enzyme inhibitors. View on treatment will change with advancing knowledge.
Related Concept Videos
01:06Coagulation
01:09Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...